A study with the diabetes vaccine Diamyd in type 1 diabetes patients.

Trial Profile

A study with the diabetes vaccine Diamyd in type 1 diabetes patients.

Planning
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs GAD65 vaccine (Diamyd) (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Aug 2017 New trial record
    • 10 Aug 2017 According to a Diamyd Medical AB media release, Chief Investigator is Professor Colin Dayan and Principal Investigator is Dr. Danijela Tatovic.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top